Exercise Training for Stroke Survivors
(HST2 Trial)
Trial Summary
What is the purpose of this trial?
People who had a stroke at least 6 months prior and who still have difficulty with walking will each be randomly assigned to receive either moderate or vigorous intensity walking exercise. Both protocols will be performed individually with a physical therapist for 45 minutes, 3x/week for 12 weeks. Measures including walking function will be assessed at baseline (PRE), after 4, 8 and 12 weeks of training (12WK) and at 3-month follow up (3moPOST), by raters who are unaware of the participant randomization.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment High-Intensity Interval Training for stroke survivors?
Research shows that High-Intensity Interval Training (HIIT) can improve walking ability and aerobic fitness more effectively than moderate-intensity aerobic training for stroke survivors. Studies have also found that HIIT is more effective than traditional aerobic exercise in improving fitness and mobility in other populations, such as healthy adults and people with heart disease.12345
Is high-intensity interval training (HIIT) safe for stroke survivors?
How does the treatment of high-intensity interval training (HIIT) differ from other treatments for stroke survivors?
High-intensity interval training (HIIT) is unique because it involves short bursts of intense exercise followed by rest periods, which can improve aerobic capacity and functional recovery more effectively than traditional moderate-intensity aerobic training. This approach has shown promise in enhancing fitness and mobility in stroke survivors, although its safety and specific protocols need further study.12359
Research Team
Pierce Boyne, PT, DPT, PhD
Principal Investigator
University of Cincinnati
Eligibility Criteria
This trial is for individuals who had a stroke at least 6 months ago and are experiencing walking difficulties. They should be able to participate in physical therapy sessions three times a week for 12 weeks, with follow-up assessments.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either moderate or vigorous intensity walking exercise with a physical therapist for 45 minutes, 3 times a week for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 3-month follow-up
Treatment Details
Interventions
- High-Intensity Interval Training (Behavioral Intervention)
- Moderate-Intensity Aerobic Training (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Cincinnati
Lead Sponsor
Dr. Greg Postel
University of Cincinnati
Chief Medical Officer since 2020
MD from Indiana University School of Medicine
Dr. Neville G. Pinto
University of Cincinnati
Chief Executive Officer since 2017
PhD in Chemistry from the University of Virginia
University of Delaware
Collaborator
Harry Jiannan Wang
University of Delaware
Chief Executive Officer since 2023
PhD in Business Administration from Pennsylvania State University
Dr. Kenneth Gene Yancey
University of Delaware
Chief Medical Officer
MD from Harvard Medical School
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Dr. Diana W. Bianchi
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Executive Officer since 2016
MD from Stanford University
Dr. Alison Cernich
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Medical Officer since 2020
PhD in Clinical Psychology from University of Maryland
University of Kansas Medical Center
Collaborator
Dr. Steve Stites
University of Kansas Medical Center
Chief Executive Officer
MD from University of Kansas School of Medicine
Dr. Matthias Salathe
University of Kansas Medical Center
Chief Medical Officer
MD from University of Kansas School of Medicine